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Abstract Prothymosin a (ProTa) is a highly acidic nuclear 
protein, once believed to have an extracellular immunoregulatory 
role but more recently implicated in cell proliferation and/or 
differentiation. Several recent studies have revealed that ProTa 
mRNA is present during embryogenesis. However, these studies 
did not investigate the spatial distribution of ProTa mRNA in the 
embryo. Here we present a detailed study of the spatial distribu- 
tion of ProTa mRNA during the early stages of postimplantation 
development (6.5--12.5 dpc) of the mouse. Three findings are of 
particular interest. First, ProTa mRNA levels increase during 
the early postimplantation stages (6.5-8.5 dpc) of mouse embryo- 
genesis. Second, ProTcx mRNA is not uniformly distributed in the 
mouse embryo, but is present in a spatially specific manner. 
Third, we have observed that the mouse ProTa gene is expressed 
almost exclusively in ectodermal and mesoderm-derived struc- 
tures, and not in cells which give rise to the definitive endoderm. 
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1. Introduction 
ProT~ is a highly acidic 12.5 kDa polypeptide originally 
isolated from rat thymus [1,2] and subsequently detected in a 
wide range of organisms and tissues [3-5]. There is a high 
degree of homology among the ProT~ and ProTa cDNAs of 
different species [6 11]. In humans, ProT~ is encoded in a gene 
family composed of six members [8]. One of these genes, con- 
taining five exons, gives rise by alternative splicing to two 
ProT~ mRNA species, while the other five genes appear to be 
pseudogenes [8]. Human ProTc~ gene has been localized to 
chromosome 2 [12]. 
It was once believed that ProTc~ function was involved in 
immune responses [3,13,14]. However, the presence of both the 
protein [15] and its mRNA [9,16] in a wide variety of tissues and 
organisms, the lack of a hydrophobic signal in the ProT~ se- 
quence [6-11] and the finding that ProTc~ mRNA is localized 
exclusively on free polysomes [8], are strong arguments against 
the possibility of an immunological role. On the other hand, a 
putative nuclear localization signal was detected in the ProT~ 
cDNA sequence [17] and several experimental approaches 
[18-21] have provided evidence that this polypeptide has a 
nuclear site of  action. Furthermore, there is good evidence to 
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Abbreviations." ProT~, prothymosin ~; dpc, days post coitum; RPA, 
RNase protection assay. 
suggest that ProT~ has a role in cell proliferation activity 
[7,9,14,22,23]. The fact that cells in which ProT~ mRNA has 
been blocked with antisense oligomers cannot divide [24] 
strongly supports this theory. Recent findings indicate that the 
biological function of ProTc~ is in some way regulated by a 
phosphorylation mechanism which is highly dependent on cell 
proliferation activity [25-27]. 
Although ProT~ mRNA levels during embryogenesis have 
been analysed before [9,22], there have been no studies of the 
spatial distribution of ProT~ mRNA in the embryo. To further 
investigate the role of ProT~ during development, we have used 
in situ hybridization to map the distribution of ProTc~ mRNA 
in the early postimplantation mouse embryo. 
2. Materials and methods 
2.1. Cloning of the mouse ProTa cDNA 
To obtain the mouse ProTa cDNA, a mouse thymus cDNA library 
(Stratagene) was screened with a human ProTa probe at low stringency. 
To obtain the human ProTc~ probe, oligonucleotide primers comple- 
mentary to nucleotides 295-315 (5') and 370-390 (3') of the human 
ProT~ cDNA [7], flanked with additional 5' nucleotides coding for the 
EcoRI restriction site, were used as primers in a standard PCR ampli- 
fication reaction [28] using 5 pg of human genomic DNA (denaturation 
95°C, 25 s; annealing 58°C, 30 s; elongation 72°C, 30 s; 40 cycles). The 
PCR product was gel-purified, extracted twice with phenol~zhloro- 
form, and ethanol-precipitated with 20 pl of glycogen as carrier. The 
precipitate was then resuspended and digested with EcoRI, and the 
resulting fragments inserted into the EcoRI site of pGEM7Zf(+) 
(Promega) using standard procedures [28]. The subcloned amplification 
product was sequenced to confirm its identity as human ProTon. A 
32p-labelled copy of the insert of this subclone was obtained using a 
random prime labelling kit (Pharmacia), and then used as probe to 
screen a mouse thymus cDNA library (Stratagene) at low stringency. 
Plaque lifts were hybridized in 5 × SSC, 10 x Denhart's, 0.5% SDS, 
100gg/ml salmon sperm DNA, at 65°C. Final wash conditions were 
1 x SSC, 0.2% SDS at 55°C. Individual hybridizing clones were plaque- 
purified and phage inserts were subcloned in pBluescript (Stratagene) 
using the in vivo excision technique (Stratagene). The longest clone was 
sequenced on both strands by the dideoxy technique using the Se- 
quenase nzyme (US Biochemical Corporation). 
2.2. Mouse embryos 
Following cervical dislocation of pregnant females, the conceptuses 
were removed and dissected free of decidua in phosphate-buffered 
saline (PBS). Noon of the day of plug was taken to be 0.5 days post 
coitum (dpc). Dissection of postimplantation embryos was as descibed 
by Cockroft [29]. 
2.3. Ribonuclease protection analyses ( RPA ) 
Total RNA was isolated from embryos by the acid guanidinium 
thiocyanate-phenol-chloroform technique [28]. RPA was performed 
with the RPAII Ribonuclease Protection Assay kit (Ambion). 3Zp-la- 
belled antisense RNA probes were obtained using the Boehringer RNA 
transcription kit from pBluescript plasmids containing a 372 bp Dpnl 
MaelI fragment of the mouse thymus ProTa cDNA. In each assay, 
1 × 10 ~° cpm of riboprobe was used. 
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2.4. Reverse transcription-polymerase chain reaction (RT-PCR) 
Whole-embryo RNA was purified and reverse-transcribed as per 
[30]. The resulting cDNA was amplified for 60 cycles of PCR and 
separated by electrophoresis in agarose [28]. Oligonucleotides comple- 
mentary to the 171 203 (5') and 489 508 (3') nucleotides of the mouse 
ProT~x cDNA El 1], flanked with additional 5' nucleotides coding for the 
EeoRI restriction site, were used as primers in PCR. The PCR product 
(PTI33) was subcloned and sequenced as described in section 2.1. 
2.5. Whole mount in situ hybridization 
Whole mount in situ hybridization was done as per Wilkinson [31] 
with 10-h incubation. The signal was detectable within 20 min. Photo- 
graphs were taken under an Olympus SHZ zoom stereo microscope 
with a darkfield stand. 
3. Results and discussion 
3.1. Isolation o f  a mouse ProT~x cDNA clone 
This article presents a detailed study of the spatial distribu- 
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Fig. 2. Spatial distribution of ProT~ transcripts in early postimplanta- 
tion mouse embryos (6.5 10.5 dpc). Unless otherwise stated, embryos 
are oriented so that anterior is at left and dorsal is at the top of page. 
(A) Hybridization labelling of a 6.5 dpc whole-mount embryo. ProT~ 
mRNAs are present in the ectoplacental cone (EC) and in a small patch 
of epiblast cells at the anterior of the streak (arrow). An embryo hybrid- 
ized with a sense ProT~ riboprobe is shown as a control. (B) Hybridi- 
zation labelling of a 8.5 dpc whole-mount embryo. ProTc~ mRNAs are 
widely distributed and are present at particularly high density in the 
cephalic mesenchyme (CM), presomitic mesoderm (PM) and intra- 
embryonic mesoderm (M). An embryo hybridized with a sense ribo- 
probe is shown as a control. (C,D) Hybridization labelling of a 9.5 dpc 
whole-mount embryo with sense (C) and antisense (D) ProTc~ ribo- 
probes. High densities of ProTc~ mRNA were detected in the 
prosencephalon (PE), in the branchial arches (BA), in the forelimb ud 
(FB) and in the posterior somites (arrowheads). No transcripts were 
detected in the region overlying the midbrain or in the heart (H). (E,F) 
Higher magnifications of the branchial (E) and tail (F) regions of the 
9.5 dpc whole-mount embryo shown in (D). (G) A control 10.5 dpc 
embryo hybridized with sense ProTc~ probe is shown to indicate the 
intensity of background staining. (H) Hybridization labelling of a 10.5 
dpc whole-mount embryo. Transcripts are abundant in many areas of 
the brain, and are present at particularly high densities prosencephalon 
(PE), in the tail bud (TB), branchial arches (BA), the apical region of 
the forelimb bud (LB) and the dorsal border of the neurocoel (NE). 
Arrowheads point to the somites. Scale bars indicate 280/lm (A), 390 
/.tin (B), 270 ,urn (C,D), 100 ~m (E,F), 330/lm (G,H). 
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tlon of ProTc~ mRNA during early post implantat ion develop- 
ment of the mouse (6.5 12.5 dpc). As a first step we isolated 
a mouse thymus ProTu cDNA. Oligonucleotide primers com- 
plementary to nucleotides 295-315 and 370 390 of the human 
ProT~ cDNA [7], which span exon 3, were used as primers in 
a standard PCR amplif ication using human genomic DNA. 
The 100 bp amplif ication product was subcloned and the insert 
of the subclone was used as a probe to screen a mouse thymus 
cDNA library. The 1.3 kb insert of the identified clone was 
subcloned and sequenced. Compar ison of the sequence of the 
mouse thymus cDNA clone with the sequence of the murine 
ProT~ previously isolated [11] confirms that the isolated clone 
encoded the mouse ProT~ homologue (data not shown). 
3.2. Pro To~ expression in early postimplantation embryos 
We were interested in determining if ProTc~ is involved in 
early events in the developing mouse embryo. To achieve this 
objective, ProT~ mRNA levels during the early postimplanta- 
tion stage (6.5 to 12.5 dpc) were examined by RPA (Fig. IA). 
ProTc~ transcripts were first detected at 7.5 dpc and were pres- 
ent in the subsequent stages studied; no transcripts were de- 
tected at 6.5 dpc by this method (Fig. 1A). However, since we 
4--  
Fig. 1. ProT~ RNA levels in postimplantation mouse embryos. (A) 
10/zg of total RNA from embryos at the day of gestation i dicated was 
analysed by RPA using the 372 bp DpnI-MaeII fragment of the mouse 
thymus ProTc~ cDNA. A fl-actin riboprobe was used for control of 
RNA integrity and loading. (B) RT-PCR analyses of ProTc~ mRNA 
levels in 6.5 dpc embryos. RT-PCR was done as described in section 
2. Lane 1 corresponds to 20 pg of 6.5 dpc embryo RNA. The RT-PCR 
product (PTI33) was purified and subcloned as described in section 2. 
(C) Comparison of the sequence of the RT-PCR product obtained in 
(B) and the sequence of the mouse ProT~ cDNA E1 I]. The 336 bp region 
of overlap shows 99.7% sequence homology. 
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suspected that RPA is not sufficiently sensitive to detect very 
low levels of ProT~ mRNA, we used RT-PCR, (which can 
detect as few as 10-100 transcripts in a single cell [30]), to check 
the RPA result. A ProT~ signal was detected in 20 pg of 
6.5 dpc embryo RNA (Fig. 1B). The RT-PCR product was 
subcloned and sequenced. Fig. 1C shows the sequence of the 
subcloned RT-PCR product alongside that of the mouse ProTc~ 
cDNA [11]. Sequence analyses confirmed that the RT-PCR 
product (PTI33) obtained from 6.5 dpc embryo RNA was 
ProTon. Taken together, these results how that ProTc~ mRNA 
levels are very low at 6.5 dpc, increase between 6.5 and 8.5 dpc, 
and remain roughly constant between 8.5 and 12.5 dpc. 
3.3. Investigation of  the spatial distribution of Pro Tc~ transcripts 
by whole-mount in situ hybridization 
To further characterize the pattern of ProTc~ mRNA synthe- 
sis during postimplantation development, we investigated the 
spatial distribution of ProT~ transcripts over the early postim- 
plantation stage (6.5 dpc to 10.5 dpc) by whole-mount in situ 
hybridization. On the basis of previous reports, we expected 
ProTcx to have a fairly uniform distribution, but our results 
revealed that mouse ProT~ is expressed in a spatially specific 
manner in the early stages of mouse development. Only very 
low levels of ProT~ transcripts were detected at 6.5 dpc (Fig. 
2A), confirming the results of RT-PCR. At this stage, ProT~ 
mRNAs were detected in a small patch of cells in the anterior 
part of the streak (Fig. 2A), and in extra-embryonic regions 
such as the ectoplacental cone, the chorion and the allantois 
(Fig. 2A). In 7.5 dpc embryos, low levels of ProT~ mRNA were 
present in the non-streak embryonic mesoderm and in the pre- 
sumptive head-fold (results not shown). By 8.5 dpc, ProT~ 
mRNA was widely distributed (Fig. 2B) and present at partic- 
ulary high density in the cephalic mesenchyme, the presomitic 
mesoderm and the intra-embryonic mesoderm. At 9.5 dpc, dis- 
tribution of ProT~ mRNA was extremely complex (Fig. 2D): 
transcripts were present at high levels in the first and second 
branchial arches, in the forelimb bud and in the midbrain (Fig. 
2D,E), and at very high levels in the posterior somites and tail 
bud (Fig. 2D,F); however, no transcripts were detected in the 
region overlying the midbrain, in the optic eminence or in the 
heart (Fig. 2D,E). At 10.5 dpc, the pattern reached by 9.5 dpc 
basically persisted. Transcripts were present at high density in 
the maxillary component of the first branchial arch and in the 
mandibular, hyoid and visceral arches (Fig. 2H), and at very 
high density in the tail bud, the apical region of the forelimb 
bud and the dorsal border of the neurocoel (Fig. 2H). Tran- 
scripts were also observed in the telencephalon, midbrain and 
forebrain, as well as in the area surrounding the auditory vesicle 
(Fig. 2H). No transcripts were detected in the anterior somites 
(although low levels were detected in the dorsal border of the 
posterior somites) or in the heart bulge. The tail bud contains 
the remnants of the primitive streak [32]: the high level of 
ProTc~ mRNA detected in this area in 10.5 dpc embryos is thus 
in accordance with that observed in 6.5 and 7.5 dpc embryos. 
This is also the area in which 'secondary neurulation' takes 
place. During this process, and by means of extremely active 
cell division, an undifferentiated mesenchyme begins to organ- 
ize dorsally and to cavitate, forming the neural tube of the tail 
[32]. Thus, the high density of ProTc~ transcripts in this area 
could reflect a relationship between the function of ProT~ and 
the high rate of cell migration and proliferation. A similar 
conclusion is suggested by the distribution of ProT~ mRNAs 
in the forelimb bud, were transcripts are present at high density 
in the apical ectodermal ridge and at lower density in the prox- 
imal core (Fig. 2D,E,H). In the developing mouse forelimb, the 
apical ectodermal ridge is an area of extremely intense mitotic 
activity which acts as a progress zone of undifferentiated me- 
senchyme [33]. Thus as in the tail bud, there is a close correla- 
tion between ProT~ levels and cell migration/proliferation 
activity. The distribution of ProT~ mRNAs in the branchial 
region of the head (Fig. 2D F) likewise strongly supports a 
relationship between cell migration and ProTcz function. In this 
area, the interface between the hindbrain eural plate and the 
surface ectoderm gives rise to neural crest cells which interact 
with other head tissues, thus contributing to a series of cranial 
ganglia and branchial arches [33]. The spatial organization of 
crest migration [33] parallels the gradient of ProT~ observed in 
the branchial arches. Futhermore, it is important to emphasize 
that the distribution of ProT~ observed in the branchial region 
of the head and in the tail and limb buds parallels that of the 
expression of a number of important regulatory genes [35-37]. 
In the course of this study we have observed that the mouse 
ProT~ gene is expressed almost exclusively in ectodermal (fore- 
limb bud, brain, branchial arches, neuroepithelium) and meso- 
derm-derived (tail bud) structures, and not in cells which give 
rise to the definitive ndoderm. No expression was detected in 
endoderm-derived organs such as the heart. The functional 
implications of this observation are not clear and will be the 
subject of future studies. 
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